Standard BioTools up on $20 mln share repurchase program
** Shares of Standard BioTools Inc LAB.O rise 18.5% to
$1.54
** Medical device maker authorizes repurchase of $20 mln of
its common stock urn:newsml:reuters.com:*:nGNX5QKdXN
** Repurchases expected to be made using cash on hand - LAB
** Including session's gain, stock down ~62% YTD
(Reporting by Khushi Mandowara)
((Khushi.Mandowara@thomsonreuters.com;))
Recent news on Standard BioTools
See all newsBrief: Standard Biotools Announces Agreement To Sell Microfluidics Business To Archimed
Brief: Standard Biotools Provides Update On Sale Of Mass Cytometry Business
Standard BioTools Inc. reports results for the quarter ended June 30 - Earnings Summary
Standard BioTools Q2 revenue falls on consumables weakness
Brief: Standard BioTools Q2 EPS USD -0.07